The human plasma protein factor I-I, which is a multifunctional, multidomai
n protein, acts as a central regulator of the complement system. In additio
n to its complement regulatory activities, factor H has multiple physiologi
cal activities and 1) acts as an extracellular matrix component, 2) binds t
o cellular receptors of the integrin type, and 3) interacts with a wide sel
ection of ligands, such as the C-reactive protein, thrombospondin, bone sia
loprotein, osteopontin, and heparin. Recent genetic reports, which show inv
olvement of factor H in the human disease hemolytic-uremic syndrome (HUS),
have attracted the attention of both clinicians and basic complement resear
chers to the role of factor II in the pathophysiology of HUS.